Possible impact of plasma RNase activity on immune dysfunction in juvenile diabetes mellitus

Pediatric Diabetes

Volumn 6, Issue 3, 2005, Pages 155-160

  Kocic, Gordana ^a   Bjelakovic, Gordana ^a   Saranac, Ljiljana ^a   Zivic, Sasa ^a   Jevtovic, Tatjana ^a   Sokolovic, Dusan ^a   Pavlovic, Dusica ^a   Pavlovic, Radmila ^a   Kocic, Radivoj ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Acid soluble nucleotides; Juvenile diabetes; RNase

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN A1C; NUCLEIC ACID; OLIGONUCLEOTIDE; PANCREATIC RIBONUCLEASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; ENZYME ASSAY; HEPARINIZATION; HUMAN; HYPOTHESIS; IMMUNOPATHOLOGY; JUVENILE DIABETES MELLITUS; METABOLIC REGULATION; NUCLEIC ACID METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 24044504031     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-543X.2005.00122.x     Document Type: Article

References (32)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994: 331: 1428-1436.
2. Maclaren N, Atkinson M. Is insulin-dependent diabetes mellitus environmentally induced? N Engl J Med 1992: 327: 348-349.
3. Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985: 313: 353-360.
4. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003: 15: 5-11.
5. Edwards AD, Diebold SS, Slack EM et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha + DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003: 33: 827-833.
6. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis E Sousa C. Innate antiviral response by means of TLR7-mediated recognition of single-stranded RNA. Science 2004: 303: 1529-1531.
7. World Health Organization. 1985 World Health Organization technical report series, 727: diabetes mellitus. Report of a WHO Study Group. Geneva: WHO.
8. Bartoleynes J, Peeters-Joris C, Reychler H, Baudhun P. Hepatic nucleases. 1. Method for the specific determination and characterization in rat liver. Eur J Biochem 1975: 57: 205-211.
9. Thomas JM, Hodes ME. Isozymes of ribonuclease in human serum and urine. I. Methodology and survey of a control population. Clin Chim Acta 1981: 111: 185-197.
10. Liu KD, McKee EE, Fritz JP. Increase of rat liver ribonuclease inhibitor level during the neonatal period. Growth 1975: 39: 167-175.
11. Mizuno NS, Sautter JH, Schultze MO. Acid-soluble nucleotides in bovine thrombocytes. J Biol Chem 1960: 235: 2109-2111.
12. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982: 126: 131-138.
13. Gendek-Kubiak H, Grzegorczyk J, Gendek EG, Kowalski ML, Berner J. Pre-operative levels of serum immunoglobulins, circulating immune complexes and complement proteins in patients with different types of neoplasms. Arch Immunol Ther Exp 2001: 49 (Suppl. 2): S89-S95.
14. Nezlin R, Alarcon-Segovia D, Shoenfeld Y. Immunochemical determination of DNA in immune complexes presented in circulation of patients with systemic lupus erythematosus. J Autoimmun 1998: 11: 489-493.
15. Gilkeson GS, Mudgett JS, Seldin MF et al. Clinical and serologic manifestations of autoimmune disease in MRL-1pr/1pr mice lacking nitric oxide synthase type 2. J Exp Med 1997: 186: 365-373.
16. Schein CH. From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases. Nat Biotechnol 1997: 15: 529-536.
17. Suhadolnik RJ, Reichenbach NL, Hitzges P et al. Changes in the 2-5A synthetase/RNaseL antiviral pathway in a controlled trial with poly(I) poly(C12U) in chronic fatigue syndrome. In Vivo 1994: 8: 599-604.
18. Leimoni ID, Sideris DC, Fragoulis EG. Purification from normal human plasma and biochemical characterization of a ribonuclease specific for poly(C) and poly(U). Arch Biochem Biophys 2003: 413: 83-90.
19. Akagi K, Murai K, Hirao N, Yamanaka N. Purification and properties of alkaline ribonuclease from human serum. Biochim Biophys Acta 1976: 442: 368-378.
20. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001: 14: 778-809.
21. Rebouillat D, Hovanessian AG. The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 1999: 19: 295-308.
22. Tsuji H, Murai K, Akagi K, Fujishima M. Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B. Clin Chem 1990: 36: 913-916.
23. Bonnevie-Nielsen V, Larsen ML, Frifelt JJ, Michelsen B, Lernmark A. Association of IDDM and attenuated response of 2′,5′-oligoadenylate synthetase to yellow fever vaccine. Diabetes 1989: 38: 1636-1642.
24. Englebienne P. RNase L in health and disease: what did we learn recently? J Chronic Fatigue Syndr 2003: 11: 97-109.
25. Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T. Cloning and characterization of an RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway. J Biol Chem 1995: 270: 13308-13317.
26. Martinand C, Montavon C, Salehzada T, Silhol M, Lebleu B, Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and downregulates the 2-5A/RNase L pathway in human T cells. J Virol 1999: 73: 290-296.
27. Maksimovich MB. Serum nucleases as nonspecific anti-viral factors and their role in artificial anti-influenza. Vopr Virusol 1984: 29: 682-687.
28. Calder PC. Dietary nucleic acids and Th1/Th2 balance: a clue to cow's milk allergy? Clin Exp Allergy 2000: 30: 908-911.
29. Barry M, Pinto-Gonzales D, Orson FM, Mckenzie GJ, Petry SR, Barry MA. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after nacked DNA injection. Hum Gene Ther 1999: 10: 2461-2480.
30. Macanovic M, Sinicropi D, Shak S, Baughman S, Thiru S, Lachmann PJ. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol 1996: 106: 243-252.
31. Van Buren C, Kulkarni AD, Schandle VB, Rudolph FB. The influence of dietary nucleotides on cell-mediated immunity. Transplantation 1983: 36: 350-352.
32. Snowdon DA, Phillips RL. Does a vegetarian diet reduce the occurrence of diabetes? Am J Public Health 1985: 75: 507-512.